Mutual Fund Research

Nippon India Pharma Fund(G)

As on Feb-23-2024 change fund
436.00  up0.91 (0.21%)

fund objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 23-Feb-2024)143.39250.18290.14270.59436.00
Net Assets(Rs Crores) (as on 23-Feb-2024) 2189.84 4260.99 4931.89 4304.46 6891.31
Scheme Returns(%)(Absolute)-5.8377.3614.83-6.8560.87
B'mark Returns(%)(Absolute)NANANANANA
Category Rank14/7532/7543/7565/7612/87
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2023-202417.1011.2311.58NA
2022-2023-10.128.200.15-4.25
2021-202222.060.731.97-7.50
2020-202131.5919.5012.24-1.15
2019-2020-6.50-1.118.38-5.70
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...13.50 
Lupin Ltd.8.31 
Cipla Ltd.6.08 
Apollo Hospitals Enterprise Ltd.5.98 
Dr. Reddy's Laboratories Ltd.4.89 
Gland Pharma Ltd.4.83 
Divi's Laboratories Ltd.4.53 
Aurobindo Pharma Ltd.3.84 
JB Chemicals & Pharmaceuticals...3.63 
Narayana Hrudayalaya Ltd.3.34 

Category

Sector Funds

Launch Date

05-Jun-04

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

6,891.31

portfolio price to book value

7.65

investing style?

Large Growth

fund manager?

Sailesh Raj Bhan

inception date (regular plan)

05-Jun-04

expense ratio (regular plan) %

1.85

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs81.02
Hospital & Healthcare Services16.82
Business Support1.22
Plastic Products0.16

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20046,891.3161.5721.3524.0617.6021.08
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19992,431.4462.2421.9725.0215.8316.29
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20183,566.5264.2321.4625.72NA21.97
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015842.8159.7320.8324.62NA12.15
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20182,178.7757.6220.7227.38NA25.81
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019648.7064.4319.81NANA23.94
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20182,161.1754.8619.7725.29NA22.41
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005919.3358.1518.8822.6514.1618.33
LIC MF Healthcare Fund-Reg(G)Large-Growth 28-Feb-201958.2250.7914.72NANA19.25
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021151.4353.87NANANA15.08
Kotak Healthcare Fund-Reg(G)Large-Growth 11-Dec-2023250.91NANANANA14.95
HDFC Pharma and Healthcare Fund-Reg(G)Large-Growth 04-Oct-2023732.29NANANANA25.97
Quant Healthcare Fund-Reg(G)Large-Growth 17-Jul-2023236.34NANANANA38.76
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Tel : 22702326
Email id : assist@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Subscribe

For all the Latest Market News, Investment Ideas.

Follow us

AMFI Registration No:88227

A Reliabull Financial Services Venture

Designed & Developed by  Accord Fintech Pvt. Ltd.